Market Tracker

01/20 5:16pm ET

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

24.20
Delayed Data
As of Jan 20
 +0.10 / +0.41%
Today’s Change
17.92
Today|||52-Week Range
36.83
-30.46%
Year-to-Date
Is AMAG Pharmaceuticals (AMAG) A Good Value Pick?
Jan 19 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for January 9th
Jan 09 / Zacks.com - Paid Partner Content
AMAG, Palatin Ink Deal to Focus on Female Sexual Disorder
Jan 10 / Zacks.com - Paid Partner Content
Trump threat fails to halt drug price hikes in 2017
Jan 04 / CNNMoney.com
Why AMAG Pharmaceuticals, Inc. Is Falling Today
Jan 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close24.10
Today’s open24.10
Day’s range23.55 - 24.35
Volume835,036
Average volume (3 months)1,050,871
Market cap$827.9M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-82.73%
Earnings growth (this year)+544.39%
Earnings growth (next 5 years)+0.02%
Revenue growth (last year)+236.28%
P/E ratio56.3
Price/Sales2.55
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
CRSPCRISPR Therapeutics ...-1.03-4.90%
RTRXRetrophin Inc+0.20+1.04%
XLRNAcceleron Pharma Inc-0.04-0.16%
MYOVMyovant Sciences Ltd-0.09-0.79%
Data as of 4:01pm ET, 01/20/2017

Financials

Next reporting dateMarch 3, 2017
EPS forecast (this quarter)$1.87
Annual revenue (last year)$418.3M
Annual profit (last year)$32.8M
Net profit margin7.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts